Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Early dissemination of bevacizumab for advanced colorectal cancer: a prospective cohort study.

Early dissemination of bevacizumab for advanced colorectal cancer: a prospective cohort study. BMC Cancer. 2011 Aug 16; 11:354.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.